Get started
Author

Erin R. Scheidemann

Observed name: Erin R Scheidemann
ORCID: 0000-0001-9187-9126
Observed ORCID: 0000-0001-9187-9126
OpenAlex ID: A5005910309
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
2021 · Erin R. Scheidemann, Ayesha N. Shajahan-Haq · International Journal of Molecular Sciences · 70
PDF
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells
2023 · Erin R. Scheidemann, Diane M. Demas, et al. · Molecular Carcinogenesis · 13
PDF
9354 Combination Of Novel Ruthenium-based Small Molecule Bold-100 And Capecitabine Is Effective In Inhibiting Growth Of Estrogen Receptor Positive Metastatic Breast Cancer
2024 · Erin R Scheidemann, Diane M Demas, et al. · Journal of the Endocrine Society · 1
Abstract 428: Low cellular pH promotes survival in CDK4/6 inhibitor resistant ER+ breast cancer
2025 · Erin R. Scheidemann, Ayesha N. Shajahan-Haq · Cancer Research
9354 Combination Of Novel Ruthenium-Based Small Molecule Bold-100 And Capecitabine Is Effective In Inhibiting Growth Of Estrogen Receptor Positive Metastatic Breast Cancer
2024 · Erin R Scheidemann, Diane M Demas, et al. · Journal of the Endocrine Society
Abstract 4758: Targeting cellular pH as a novel therapeutic strategy in CDK4/6 inhibitor resistant breast cancer
2024 · Erin R. Scheidemann, Diane M. Demas, et al. · Cancer Research
Works count: 6
Citation count: 84
H-index: 2
I10-index: 2
Year
Topic
Type